We are pleased to invite investors and analysts to participate in a live video webcast and conference call on Monday, 27 July, 2020, highlighting Roche data accepted for presentation via the ASRS 2020 Virtual Scientific Program July 24-26, 2020.
16:30 – 17:30 CEST / 15:30 - 16:30 BST
10:30 – 11:30 am EDT / 7:30 – 8:30 am PDT
Video webcast and conference call will start with a presentation, followed by a Q&A session (live access to the speakers).
Agenda:
Welcome
Karl Mahler, Head of Investor Relations and Roche Group Planning
Ophthalmology Franchise Overview
Atul Dandekar, Vice President and Global Franchise Head of Ophthalmology Product Strategy
Review of key ophthalmology data presented at ASRS
Christopher Brittain, Vice President and Global Head of Ophthalmology Product Development
PDS: Archway – Phase III topline results
Dante J. Pieramici, M.D., Retina Specialist and Clinical Investigator
Q&A
Access to video webcast and conference call (pre-registration required)
Please pre-register for our webinar here.*
A replay of the webcast will be available via ir.roche.com
| Best regards, | |
| Karl Mahler Head of Investor Relations and Roche Group Planning |
Lisa Tuomi Investor Relations Officer |
| Roche Investor Relations | |
| Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com |
Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
| Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com |
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com |
| Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com |
Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com |
| Investor Relations North America | |
| Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
Dr. Lisa Tuomi Phone: +1 650 467 8737 e-mail: tuomi.lisa@gene.com |
get the latest news and updates to your inbox.